Summary of findings for single‐dose nasal decongestant vs placebo
Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold
1 finding from 1 review
- no estimate extracted4 studies · 540 participantsGRADE not reported